RAKESH MARWAHA: Open Payments
NPI 1164539094 · NAPERVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,419 in 124 payments from 34 companies in 2025. Trend: 2023 $2,862 · 2024 $2,292 · 2025 $2,419
Food & beverage: $2,419
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $248 |
| AstraZeneca Pharmaceuticals LP | 9 | $184 |
| PFIZER INC. | 9 | $178 |
| Kowa Pharmaceuticals America, Inc. | 12 | $164 |
| Amgen Inc. | 12 | $162 |
| Novo Nordisk Inc | 6 | $159 |
| RECORDATI_RARE_DISEASES_INC. | 5 | $120 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $113 |
| Lilly USA, LLC | 5 | $101 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $96 |
Products named: ZORYVE, ISTURISA, REXULTI, JARDIANCE, OTEZLA, MOUNJARO, CAPLYTA, SPRAVATO.
Industry payments across IL — which companies pay providers there.
